Tech Company Financing Transactions
RootPath Genomics Funding Round
RootPath Genomics closed a $11 million Series A financing round on 1/8/2020. Backers included Baidu Venture Capital, Nest.Bio Ventures and Oriza Ventures.
Transaction Overview
Company Name
Announced On
1/8/2020
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Series A
Investors
Nest.Bio Ventures (Hingge Hsu)
Oriza Ventures (Grace Yang)
Sequoia Capital (Cyber Cao)
Volcanics Venture (Suyang Zhang)
Proceeds Purpose
The company will use the Series A proceeds to validate its tumor-reactive T cell receptor (TCR) discovery workflow, select a lead therapeutic candidate, demonstrate its safety and efficacy in preclinical models and begin IND-enabling development activities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
65 Grove St. 203
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Undisclosed
Website
Email Address
Overview
RootPath is a Cambridge-based biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. Our next generation technologies allow us to precisely monitor, modulate and steer the immune system for a revolution in the diagnosis and treatment of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Xi Chen
Co-Founder
Cheryl Cui
Co-Founder
Yinqing Li
Co-Founder
Ely Porter
Browse more venture capital transactions:
Prev: 1/8/2020: Melio venture capital transaction
Next: 1/8/2020: Curricula venture capital transaction
Share this article
Where The Data Comes From
We record tech company VC transactions. All VC database entries reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs